1'758 companies found
Praed Pharmaceuticals AG
Basel · Since 2019
The core activity of Praed Pharmaceuticals is the development and marketing of pharmaceuticals, particularly the development of a next generation of treatments for Crohn's disease. The company is focused on the clinical Phase II development of a compound that already has an established CMC (Chemistry, Manufacturing and Control) and safety profile from a Phase III program.
Preclina Europe GmbH
Allschwil · Since 2024
Preclina Europe GmbH is a non-clinical CRO providing an integrated drug-discovery platform focused on immunology and inflammatory disorders. Services listed on the website include cell-based assays using patient-derived cells, histopathology services, and PK/ADME/toxicology testing.
PRECLIN Biosystems SA
Epalinges · Since 2008
PRECLIN Biosystems SA provides a comprehensive in vivo preclinical testing platform for the identification and validation of lead therapeutic candidates and specializes in preclinical models of chronic inflammatory and infectious diseases.
Premark Pharma GmbH
Reinach Bl · Since 2018
Premark Pharma GmbH develops and commercialises topical treatments for inflammatory diseases of the skin, eye, mucosae and mucocutaneous surfaces. Its lead ophthalmic assets include pimecrolimus formulations such as PMP2207 (an ointment for blepharitis) and PMP1606 (a liquid suspension for dry eye), with Phase 3 programmes planned and regulatory approvals sought in the EU and US.
Primex Pharmaceuticals AG
Zug · Since 2010
The core activity of Primex Pharmaceuticals is the development, manufacture and marketing of pharmaceuticals, particularly in the field of anesthesia and sedation, with a focus on innovative solutions for pediatric sedation.
Primopus AG
Muttenz · Since 2020
The core activity of Primopus AG is the development and manufacture of pharmaceutical active ingredients and intermediates as a Contract Development and Manufacturing Organization (CDMO). They offer services such as process development, manufacturing and backward integration of pharmaceutical active ingredients, including the production of phosphoramidites and Fmoc amino acids.
PRISMAN Pharma International AG
Egerkingen · Since 2008
The core activity of PRISMAN Pharma International AG is the development, manufacture and distribution of hygiene products, particularly chemical solutions and disinfectants.
Probiocon GmbH
Pfeffingen · Since 2012
Probiocon GmbH is a consulting firm offering tailored services to biopharmaceutical and biotechnological companies. Its main areas of activity include corporate development and strategy, as well as technical project and outsourcing management.
PROBIONOVA SA
Lugano · Since 2018
The core activity of Probionova SA is the research and development of new probiotic strains and applications for therapeutic purposes, particularly in the field of human health and microbiome. The company develops clinically evidence-based probiotics with pharmaceutical quality for therapeutic applications and offers services such as the selection and development of probiotic strains, the manufacture of probiotic combinations, and the provision of full-service solutions.
Promediol SA
Montagnola · Since 2020
The core activity of Promediol SA is the development, production and marketing of pharmaceutical products, particularly medicines and active ingredients, with the aim of improving the quality of life of people worldwide. The company focuses on the manufacture of high-quality medicines used in various fields of medicine and invests in research and development to develop new products and improve existing ones.
Prometheus Life Technologies AG
Dübendorf · Since 2022
Prosalix AG
Basel · Since 2018
The core activity of Prosalix AG is the development and research of medical products, in particular citrate-based therapies, for the treatment of kidney and metabolic diseases. The company focuses on developing innovative solutions for nephrology, urology and endocrinology, with the goal of improving the quality of life for patients.
Protaccine Biotec Sàrl
Delémont · Since 2017
The core activity of Protaccine Biotec Sarl is the development and production of high-quality anti-snake venom sera, other antiserum-based products, thermostable vaccines and biological products based on new technologies at affordable prices. Additionally, the company offers consulting services and turnkey solutions for the vaccine and biotechnology industry, and supports patients in various treatments, including cancer treatments through immunotherapy and gene therapy.
Protochemie AG
Mitlödi · Since 1949
Protzek Biotec GmbH
Reinach Bl · Since 2003
The core activity of Protzek is the development, production and distribution of objective test and analysis systems for medical, police and forensic applications, particularly in the fields of toxicology and virology, with a focus on sustainable and environmentally friendly products.
PROVECTIS HEALTHCARE AG
Basel · Since 2022
The core activity of Provectis Healthcare AG is the development, manufacture and marketing of health products, particularly in the field of nutraceuticals and dermaceuticals. The company focuses on partnering with innovative biopharma companies to establish their products on the market and provide patients worldwide with access to these solutions. Provectis supports its partners in product development, market launch and marketing to maximize the success of their products.
Pure Pharma AG
Laufenburg · Since 2019
The core activity of Pure Holding AG is the breeding, cultivation, processing and distribution of cannabis products. The company focuses on improving the safety and quality of cannabis products and offers a wide range of products, from seeds to finished products.
Qanatpharma AG
Stans · Since 2020
The core activity of Qanatpharma is the development of new therapeutic strategies for the treatment of diseases caused by microvascular dysfunction. The company is particularly focused on researching and developing medications that improve microvascular function and alleviate the effects of diseases such as cognitive decline, hypertension, and heart failure.
Quercis Pharma AG
Zug · Since 2018
The core activity of Quercis Pharma AG is the development of pharmaceuticals, particularly the research and development of medications for the prevention of thrombosis and other diseases, such as cancer and neurological disorders. The company focuses on the development of Isoquercetin-based medications, such as Kinisoquin, and conducts clinical trials to test their efficacy and safety.
Rapid Pharma Development GmbH
Unterägeri · Since 2007
The core activity of Rapid Pharma Development GmbH is the provision of services for the development of pharmaceutical projects, particularly in the areas of: project management, CMC (Chemistry, Manufacturing and Controls), GMP auditing, regulatory consulting, development of active pharmaceutical ingredients (API) and formulations, analytical activities, and outsourcing management of pharmaceutical development projects. The company supports its customers in the development of medicinal products, from the early phase to market authorization, and offers a wide range of services to accelerate and optimize the development of pharmaceutical projects.
Outbound Leads by COHAGALeadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Discover LeadhubHow the search works, what each filter means, and how the results come together.
Source: Federal Statistical Office, UID register